FDA stuns Lilly and Incyte with CRL for much-anticipated RA drug baricitinib
admin 14th April 2017 Uncategorised 0 FDA stuns Lilly and Incyte with CRL for much-anticipated RA drug baricitinib
epalmer
Fri, 04/14/2017 – 10:28
More: FDA stuns Lilly and Incyte with CRL for much-anticipated RA drug baricitinib
Source: fierce